Black Diamond Therapeutics (BDTX) Short Interest Ratio & Short Volume $2.54 -0.05 (-1.93%) (As of 01:03 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Black Diamond Therapeutics Short Interest DataBlack Diamond Therapeutics (BDTX) has a short interest of 5.94 million shares. This marks a -6.16% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.0, indicating that it would take 5.0 days of the average trading volume of 793,634 shares to cover all short positions.Current Short Interest5,940,000 sharesPrevious Short Interest6,330,000 sharesChange Vs. Previous Month-6.16%Dollar Volume Sold Short$15.56 millionShort Interest Ratio5.0 Days to CoverLast Record DateNovember 15, 2024Outstanding Shares56,580,000 sharesPercentage of Shares Shorted10.50%Today's Trading Volume274,803 sharesAverage Trading Volume793,634 sharesToday's Volume Vs. Average35% Short Selling Black Diamond Therapeutics? Sign up to receive the latest short interest report for Black Diamond Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBDTX Short Interest Over TimeBDTX Days to Cover Over TimeBDTX Percentage of Float Shorted Over Time Ad Porter & CompanyElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. Black Diamond Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/20245,940,000 shares $15.56 million -6.2%N/A5 $2.62 10/31/20246,330,000 shares $17.34 million -13.5%N/A5.2 $2.74 10/15/20247,320,000 shares $24.89 million +5.9%N/A6.2 $3.40 9/30/20246,910,000 shares $30.06 million +17.9%N/A6.2 $4.35 9/15/20245,860,000 shares $36.27 million -3.5%N/A5.2 $6.19 8/31/20246,070,000 shares $37.03 million +1.0%N/A9.4 $6.10 Get the Latest News and Ratings for BDTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Black Diamond Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/15/20246,010,000 shares $29.93 million +35.4%N/A9.4 $4.98 7/31/20244,440,000 shares $27.04 million -6.1%N/A6.4 $6.09 7/15/20244,730,000 shares $28.47 million +47.4%N/A6.2 $6.02 6/30/20243,210,000 shares $14.96 million +8.5%N/A4.1 $4.66 6/15/20242,960,000 shares $17.67 million +13.0%N/A4.4 $5.97 5/31/20242,620,000 shares $12.52 million +22.4%N/A3.9 $4.78 5/15/20242,140,000 shares $11.64 million +7.0%N/A3.3 $5.44 4/30/20242,000,000 shares $11.14 million +13.6%N/A3 $5.57 4/15/20241,760,000 shares $9.19 million -13.7%N/A2.8 $5.22 3/31/20242,040,000 shares $10.34 million +12.7%N/A3.4 $5.07 3/15/20241,810,000 shares $8.67 million +1.7%N/A3.1 $4.79 2/29/20241,780,000 shares $9.16 million -5.3%N/A3.1 $5.15 2/15/20241,880,000 shares $9.51 million -21.7%N/A3.5 $5.06 1/31/20242,400,000 shares $9.22 million -33.0%N/A4.5 $3.84 1/15/20243,580,000 shares $10.67 million -1.1%N/A7.9 $2.98 12/31/20233,620,000 shares $10.17 million -0.6%N/A7.1 $2.81 12/15/20233,640,000 shares $9.86 million +6.4%N/A7 $2.71 11/30/20233,420,000 shares $8.00 million +1.8%N/A6.2 $2.34 11/15/20233,360,000 shares $7.56 million +0.3%N/A6 $2.25 10/31/20233,350,000 shares $6.30 million +12.8%9.8%6.2 $1.88 10/15/20232,970,000 shares $6.80 million +24.3%8.7%5.6 $2.29 9/30/20232,390,000 shares $6.86 million +68.3%7.0%3.9 $2.87 9/15/20231,420,000 shares $5.04 million +24.6%4.1%0.3 $3.55 8/31/20231,140,000 shares $3.84 million +7.6%3.2%0.3 $3.37 8/15/20231,060,000 shares $3.36 million +1.9%2.9%0.3 $3.17 7/31/20231,040,000 shares $3.88 million -67.3%4.7%0.3 $3.73 7/15/20233,180,000 shares $15.42 million -38.4%14.4%0.8 $4.85 6/30/20235,160,000 shares $26.06 million +166.0%23.4%1.3 $5.05 6/15/20231,940,000 shares $4.07 million No Change8.4%31.3 $2.10 5/31/20231,940,000 shares $3.61 million No Change8.4%22.7 $1.86 5/15/20231,940,000 shares $3.74 million -1.5%8.4%24.1 $1.93 4/30/20231,970,000 shares $2.82 million No Change8.6%24.1 $1.43 4/15/20231,970,000 shares $2.94 million -1.5%8.6%22.6 $1.49 3/31/20232,000,000 shares $3.78 million -1.5%8.7%17.3 $1.89Urgent: This election is rigged (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. 3/15/20232,030,000 shares $3.41 million +3.1%8.8%13.5 $1.68 2/28/20231,970,000 shares $3.49 million -1.0%8.6%14.6 $1.77 2/15/20231,990,000 shares $5.23 million No Change8.7%14.6 $2.63 1/31/20231,990,000 shares $5.97 million -2.0%8.7%13.3 $3.00 1/15/20232,030,000 shares $5.36 million -2.4%8.9%9.6 $2.64 12/30/20222,080,000 shares $3.74 million +5.6%9.1%10 $1.80 12/15/20221,970,000 shares $2.96 million No Change8.6%10.5 $1.50 11/30/20221,970,000 shares $4.16 million -2.5%8.6%11.1 $2.11 11/15/20222,020,000 shares $4.79 million -2.4%8.8%11.2 $2.37 10/31/20222,070,000 shares $4.78 million -7.2%9.1%11.3 $2.31 10/15/20222,230,000 shares $2.83 million +6.2%9.8%14.9 $1.27 9/30/20222,100,000 shares $3.55 million No Change9.2%15.8 $1.69 9/15/20222,100,000 shares $5.50 million -3.7%9.2%11.1 $2.62 8/31/20222,180,000 shares $6.95 million -0.5%9.5%10.7 $3.19 8/15/20222,190,000 shares $8.78 million -4.0%9.6%9.7 $4.01 7/31/20222,280,000 shares $7.98 million -8.1%10.0%9.6 $3.50 7/15/20222,480,000 shares $7.79 million -5.0%10.9%9.8 $3.14 6/30/20222,610,000 shares $6.42 million -18.2%11.4%9.3 $2.46 6/15/20223,190,000 shares $6.73 million -9.9%14.0%11.5 $2.11 5/31/20223,540,000 shares $5.98 million -1.9%15.5%15.1 $1.69 5/15/20223,610,000 shares $6.39 million +1.4%15.8%15.1 $1.77 4/30/20223,560,000 shares $8.65 million +8.5%15.6%14.6 $2.43 4/15/20223,280,000 shares $11.18 million +3.8%14.4%12.1 $3.41 3/31/20223,160,000 shares $8.75 million -1.6%13.8%5.5 $2.77 3/15/20223,210,000 shares $8.86 million -1.8%14.1%5.5 $2.76 2/28/20223,270,000 shares $10.27 million +3.2%14.3%5.5 $3.14 2/15/20223,170,000 shares $12.01 million -5.9%13.9%5.3 $3.79 1/31/20223,370,000 shares $14.05 million -8.4%14.8%5.7 $4.17 1/15/20223,680,000 shares $15.60 million +19.5%14.8%6.7 $4.24 12/31/20213,080,000 shares $16.42 million +2.7%12.4%5.8 $5.33 12/15/20213,000,000 shares $15.93 million -3.9%12.1%12.9 $5.31 11/30/20213,120,000 shares $18.72 million +1.3%12.6%13.8 $6.00 11/15/20213,080,000 shares $23.56 million -5.5%12.4%13.5 $7.65 10/29/20213,260,000 shares $24.97 million -12.6%13.0%13.7 $7.66 10/15/20213,730,000 shares $30.51 million -4.1%14.9%14.8 $8.18 9/30/20213,890,000 shares $32.91 million -7.8%15.5%14.4 $8.46 9/15/20214,220,000 shares $40.68 million -0.5%16.8%13.5 $9.64 8/31/20214,240,000 shares $42.82 million +2.9%16.8%9.9 $10.10 8/13/20214,120,000 shares $38.23 million +2.0%16.4%7.4 $9.28 7/30/20214,040,000 shares $38.62 million +5.5%16.1%5.1 $9.56 7/15/20213,830,000 shares $38.45 million -1.8%15.2%4.9 $10.04 6/30/20213,900,000 shares $47.54 million -3.0%15.5%4.9 $12.19 6/15/20214,020,000 shares $51.34 million -7.2%16.0%5.3 $12.77 5/28/20214,330,000 shares $56.81 million -6.9%17.2%6.4 $13.12 5/14/20214,650,000 shares $123.50 million -0.9%18.5%8 $26.56 4/30/20214,690,000 shares $127.99 million No Change18.7%14.1 $27.29 4/15/20214,690,000 shares $116.45 million +1.1%17.3%11.6 $24.83 3/31/20214,640,000 shares $104.72 million +27.1%17.1%10 $22.57 3/15/20213,650,000 shares $96.69 million +1.4%13.5%7.9 $26.49 2/26/20213,600,000 shares $101.95 million +2.3%13.3%8.1 $28.32Urgent: This election is rigged (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. 2/12/20213,520,000 shares $98.21 million +4.5%13.0%7.9 $27.90 1/29/20213,370,000 shares $81.55 million +3.1%12.5%7.7 $24.20 1/15/20213,270,000 shares $93.59 million No Change12.1%8.9 $28.62 BDTX Short Interest - Frequently Asked Questions What is Black Diamond Therapeutics' current short interest? Short interest is the volume of Black Diamond Therapeutics shares that have been sold short but have not yet been closed out or covered. As of November 15th, investors have sold 5,940,000 shares of BDTX short. Learn More on Black Diamond Therapeutics' current short interest. What is a good short interest ratio for Black Diamond Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BDTX shares currently have a short interest ratio of 5.0. Learn More on Black Diamond Therapeutics's short interest ratio. Which institutional investors are shorting Black Diamond Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Black Diamond Therapeutics: Jane Street Group LLC, Ikarian Capital LLC, and LMR Partners LLP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Black Diamond Therapeutics' short interest increasing or decreasing? Black Diamond Therapeutics saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 5,940,000 shares, a decrease of 6.2% from the previous total of 6,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Black Diamond Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Black Diamond Therapeutics: ChromaDex Co. (4.42%), Annexon, Inc. (6.70%), Mereo BioPharma Group plc (3.63%), Humacyte, Inc. (18.46%), Verve Therapeutics, Inc. (27.07%), ABIVAX Société Anonyme (0.51%), Corvus Pharmaceuticals, Inc. (5.14%), PureTech Health plc (0.04%), Terns Pharmaceuticals, Inc. (6.40%), MeiraGTx Holdings plc (1.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks. What does it mean to sell short Black Diamond Therapeutics stock? Short selling BDTX is an investing strategy that aims to generate trading profit from Black Diamond Therapeutics as its price is falling. BDTX shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Black Diamond Therapeutics? A short squeeze for Black Diamond Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BDTX, which in turn drives the price of the stock up even further. How often is Black Diamond Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BDTX, twice per month. The most recent reporting period available is November, 15 2024. More Short Interest Resources from MarketBeat Related Companies ChromaDex Short Squeeze Annexon Short Squeeze Mereo BioPharma Group Short Squeeze Humacyte Short Squeeze Verve Therapeutics Short Squeeze ABIVAX Société Anonyme Short Squeeze Corvus Pharmaceuticals Short Squeeze PureTech Health Short Squeeze Terns Pharmaceuticals Short Squeeze MeiraGTx Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BDTX) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Black Diamond Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
